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Abstract
Objective:  The  pandemic  caused  by  inﬂuenza  A(H1N1)pdm09  virus  peaked  between  July  and
August  of  2009  in  southern  Brazil,  with  the  highest  incidence  in  children  and  young  adults.  In
the  post-pandemic  period,  there  was  an  increase  in  the  incidence  of  cases  during  the  winter
months  of  2011  and  2012  in  Brazil,  similar  to  seasonal  inﬂuenza  virus.  Since  infections  due  to
pandemic  inﬂuenza  are  still  occurring,  the  present  study  aimed  to  investigate  the  risk  factors
for  worse  outcome  in  children.
Methods: A  retrospective  cohort  study  was  performed  by  reviewing  the  charts  of  hospitalized
patients younger  than  14  years  with  reverse  transcription-polymerase  chain  reaction  (RT-PCR)
positive  for  inﬂuenza  A(H1N1)pdm09  during  the  ﬁrst  pandemic  wave  in  six  Brazilian  tertiary
centers.  Need  for  mechanical  ventilation  was  deﬁned  as  the  severity  of  outcome;  age,  chronic
diseases,  bacterial  and  viral  co-detection,  chest  radiograph  ﬁndings,  and  use  of  oseltamivir
were  possible  predictors.
 Please cite this article as: Scotta MC, Mattiello R, Maróstica PJ, Jones MH, Martins LG, Fischer GB. Risk factors for need of mechanical
entilation in children with Inﬂuenza A(H1N1)pdm09. J Pediatr (Rio J). 2013;89:444--9.
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Results:  In  the  present  study,  120  patients  were  included.  In  a  multivariate  analysis,  chronic
diseases (prevalence  ratio:  2.613,  95%  CI:  1.267-5.386)  and  viral  co-detection  (prevalence  ratio:
2.43,  95%  CI:  1.203-4.905)  were  statistically  associated  with  worse  outcome  (p  <  0.05).
Conclusions:  The  presence  of  chronic  diseases  as  predictors  reinforces  previous  ﬁnding.  Fur-
thermore, viral  co-detection  was  found  to  be  a  risk  factor.  Further  studies  are  necessary  to
conﬁrm  this  association.
© 2013  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  
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Fatores  de  risco  para  necessidade  de  ventilac¸ão  mecânica  em  crianc¸as  com  Inﬂuenza
A(H1N1)pdm09
Resumo
Objetivo:  A  pandemia  causada  pelo  vírus  Inﬂuenza  A(H1N1)pdm09  teve  seu  pico  nos  meses  de
julho  e  agosto  de  2009,  no  Sul  do  Brasil,  sendo  a  incidência  mais  alta  em  crianc¸as  e  adultos
jovens.  No  período  pós-pandêmico,  no  Brasil,  houve  aumento  de  casos  nos  meses  de  inverno
dos  anos  de  2011  e  2012,  de  forma  semelhante  ao  vírus  inﬂuenza  sazonal.  Como  ainda  estão
ocorrendo  infecc¸ões  devido  ao  inﬂuenza  pandêmico,  nosso  objetivo  foi  investigar  fatores  de
risco  para  pior  desfecho  em  crianc¸as.
Métodos:  Foi  realizado  um  estudo  de  coorte  retrospectivo  analisando  as  ﬁchas  de  pacientes
menores de  14  anos  hospitalizados  e  com  RT-PCR  positiva  para  Inﬂuenza  A(H1N1)pdm09  durante
a  primeira  onda,  em  seis  centros  terciários  brasileiros.  Deﬁnimos  a  necessidade  de  ventilac¸ão
mecânica como  desfecho  com  gravidade  e,  como  possíveis  preditores,  os  fatores  idade,  doenc¸as
crônicas, codetecc¸ão  bacteriana  e  viral,  achados  da  radiograﬁa  do  tórax  e  uso  de  oseltamivir.
Resultados: No  presente  estudo,  foram  incluídos120  pacientes.  Em  uma  análise  multivariada,
doenc¸as crônicas  (razão  de  prevalência:  2,613;  intervalo  de  conﬁanc¸a de  95%:  1,267  a  5,386)  e
codetecc¸ão  viral  (razão  de  prevalência:  2,43;  intervalo  de  conﬁanc¸a de  95%:  1,203  a  4,905)  se
associaram  estatisticamente  a  um  pior  desfecho  (p  <  0,05).
Conclusões: A  presenc¸a de  doenc¸as  crônicas  como  preditores  reforc¸a evidências  prévias.  Além
disso, veriﬁcamos  que  a  codetecc¸ão  viral  é  fator  de  risco.  São  necessários  outros  estudos  para
conﬁrmar  essa  associac¸ão.
© 2013  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  
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In  March  and  April  of  2009,  casualties  from  inﬂuenza-like  ill-
ness showed  a  rise  in  Mexico  and  the  United  States.  Caused
by a  new  strain  of  inﬂuenza  A  (H1N1),  it  rapidly  emerged
as the  new  inﬂuenza  pandemic,  which  caused  a  consider-
able number  of  deaths  by  respiratory  failure  throughout
the world  in  the  following  months.1,2 As  we  entered  the
post-pandemic period  in  August  2010,  the  virus  continues
to circulate  in  many  countries.  In  2011,  the  World  Health
Organization (WHO)  standardized  the  name  of  the  new
virus: inﬂuenza  A(H1N1)pdm09.  In  Brazil,  infections  due  to
inﬂuenza A(H1N1)pdm09  are  occurring  after  the  ﬁrst  pan-
demic wave  with  a  seasonal  pattern,  mainly  in  the  South
and Southeast  regions,  and  are  still  causing  several  deaths
each year,  mostly  in  winter  months.3 Although  in  most  pedi-
atric patients  the  disease  is  asymptomatic  or  mild,  with
self-limited course,  a  small  proportion  of  patients  die,  pri-
marily due  to  respiratory  failure.4,5 Many  respiratory  viruses
also have  seasonality  in  winter  months,  and  a  clinical  distinc-
tion between  inﬂuenza  A(H1N1)pdm09  and  other  respiratory
viruses is  difﬁcult,  because  the  signs  and  symptoms  are
not speciﬁc.6 As  a  result,  the  incidence  of  cases  deﬁned
Este as inﬂuenza-like  illness  is  usually  much  higher  than  real
inﬂuenza-associated disease.7 As  an  additional  difﬁculty,
laboratory diagnosis  of  inﬂuenza  A(H1N1)pdm09  is  prob-
lematic in  most  clinical  settings,  due  to  lack  of  sensitivity
i
a
c
wf  rapid  tests  and  direct  immunoﬂuorescence  assay  (DFA),
hich are  the  most  available  tests.8 In  an  attempt  to  bet-
er guide  interventions,  several  studies  were  conducted  in
hildren with  inﬂuenza  A(H1N1)pdm09,  searching  for  risk
actors for  worse  outcome,  deﬁned  as  intensive  care  unit
ICU) admission,  need  for  mechanical  ventilation  (MV),  or
eath.9,10 The  most  consistent  ﬁnding  as  predictor  for  these
utcomes was  the  presence  of  one  or  more  chronic  diseases
CD), particularly  neurologic  impairment.11
Others  ﬁndings,  such  as  chest  X-ray  with  diffuse  inﬁl-
rate on  admission,  anemia,  and  delay  in  the  initiation  of
ntiviral therapy  have  also  been  mentioned,  but  not  uni-
ormly observed.12,13 This  combination  of  factors  leads  to
ifﬁculties in  the  management  of  suspected  cases,  since
any of  these  patients  are  not  actually  infected  by  inﬂuenza
(H1N1)pdm09 but,  based  on  clinical  and  laboratory  ﬁnd-
ngs, it  is  not  possible  rule  out  infection.  Furthermore,
redictors to  poor  outcome  in  pediatric  patients  are  not
ompletely understood,  so  most  children  with  inﬂuenza-like
llness are  at  risk  of  unfavorable  outcome,  and  have  indica-
ion for  antiviral  therapy.
These factors  may  explain  why,  during  the  pandemic,
ocal public  health  authorities  in  Brazil  recommended  prior-
artigo Open Access sob a licença de CC BY-NC-NDty of  antiviral  treatment  for  children  younger  than  2  years,
nd for  those  with  CD.  In  2012,  these  recommendations
hanged, and  treatment  was  suggested  for  most  children
ith inﬂuenza-like  illness.14 In  this  context,  it  is  important
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o  continue  to  investigate  the  risk  factors  for  respiratory
ailure, in  order  to  obtain  more  accurate  recommendations
or vaccination  and  treatment.  This  study  aimed  to  iden-
ify the  risk  factors  for  need  of  MV  and  to  describe  deaths
hat occurred  in  children  due  to  inﬂuenza  A(H1N1)pdm09
nfections during  the  ﬁrst  pandemic  wave  in  Porto  Alegre,
outhern Brazil.
ethods
 retrospective  cohort  study  was  performed  through  the
eview of  medical  charts  of  children  admitted  to  six  ter-
iary pediatric  centers  in  Porto  Alegre,  Brazil,  during  the
rst pandemic  wave  in  2009,  from  July  2  to  October  15.
orto Alegre  is  the  southernmost  state  capital  of  Brazil,  with
 population  of  1.5  million  people.  All  pediatric  hospitaliza-
ions in  Porto  Alegre  occurred  at  one  of  the  six  hospitals
ncluded in  this  study.  All  socioeconomic  groups  were  con-
idered in  these  six  institutions,  with  one  private  hospital,
wo partially  private,  and  three  public  hospitals.  All  patients
ounger than  14  years  who  had  laboratory-conﬁrmed  infec-
ion with  inﬂuenza  A(H1N1)pdm09  determined  by  reverse
ranscription-polymerase  chain  reaction  (RT-PCR),  were  eli-
ible. Local  guidelines  recommended  testing  all  children
dmitted with  inﬂuenza-like  illness  during  the  pandemic.
hose whose  medical  charts  were  incomplete  to  allow
ata collection  of  possible  predictors  and  outcome  and
hose whose  medical  charts  were  not  found  were  excluded.
ll patients  names  were  provided  by  the  Rio  Grande  do
ul Health  Department,  the  division  responsible  for  the
ctive surveillance  and  testing  of  inﬂuenza  A(H1N1)pdm09.
ll charts  were  reviewed  by  the  same  investigator.  Need
or invasive  or  non-invasive  MV  attributed  to  inﬂuenza  A
H1N1)pdm09 was  deﬁned  as  the  main  outcome,  as  a  sur-
ogate for  outcome  severity,  and  the  possible  predictors
mong patients  who  required  MV  and  those  who  did  not
ere compared.  The  independent  variables  investigated  as
ossible predictors  for  the  outcome  were  gender,  age,  CD,
acterial and  viral  co-detection  during  clinical  course,  ini-
iation of  oseltamivir  before  and  after  48  hours  of  signs  and
ymptoms, and  abnormalities  in  report  of  chest  X-ray  at
dmission (diffuse  interstitial  inﬁltrate,  consolidation,  or
oth). ‘‘Use  of  oseltamivir’’  was  considered  only  in  patients
ho actually  received  medication  in  the  correct  dose  for  5
ays. Correct  doses  were,  for  those  older  than  1  year,  75,  60,
5,  and  30  (mg)  twice  daily  for  weight  rangers  greater  than
0 kg,  23-40  kg,  15-23  kg,  and  less  than  15  kg,  respectively.
n children  younger  than  1  year  of  age,  the  doses  considered
orrect were  25,  20,  and  12  mg  twice  daily  for  ages  6-11,
-5, and  less  than  3  months,  respectively.15
It  was  decided  to  deﬁne  bacterial  and  viral  co-detection
nstead of  co-infection  since  the  causal  link  between
athogen detection  and  disease  is  not  always  possible.  Bac-
erial co-detection  was  deﬁned  as  a  positive  culture  for  a
ossible pathogen  in  respiratory  secretions,  blood,  or  other
terile ﬂuid.  Viral  co-detection  was  deﬁned  as  the  ﬁnding  of
ne or  more  different  viruses  detected  in  respiratory  secre-
ion samples  determined  by  RT-PCR  or  DFA.  Performing  DFA
an detect  respiratory  syncytial  virus  (RSV),  parainﬂuenza
 to  3,  adenovirus,  and  inﬂuenza  A  and  B.  Tests  were  per-
ormed in  the  same  specimens  by  RT-PCR  in  the  majority
a
n
s
cScotta  MC  et  al.
f  cases,  or,  at  most,  48  hours  apart.  Chronic  diseases  were
eﬁned as  diagnosis  of  chronic  cardiac  and  respiratory  dis-
rders, neurologic  impairment,  chronic  renal  insufﬁciency,
alignancy, and  immunosuppression  based  on  the  diagnosis
rovided on  the  charts.  As  a secondary  objective,  patients’
eaths were  described  in  detail,  as  well  as  the  performance
f DFA  for  inﬂuenzaA(H1N1)pdm09,  comparing  to  RT-PCR.
ith a  convenience  sample  of  130  patients,  expecting  that
5% of  the  children  will  need  MV,  a  risk  of  2.5  between
he predictor  variables  and  the  outcome  was  detected.
emographics were  summarized  as  mean  or  median  and
nterquartile range  according  to  their  distribution.  Poisson
egression with  robust  variance  was  used  to  analyze  the  rela-
ionships  between  the  main  outcome  (use  of  MV)  and  the
redictor variables  (gender,  age,  CD,  presence  of  viral  co-
etection, use  of  oseltamivir,  and  abnormal  chest  X-ray).16
he  Wald’s  test  was  used  to  assess  statistical  signiﬁcance.
nitially, all  covariates  that  presented  p  <  0.10  were  included
n the  multivariate  model.  The  next  step  was  the  individual
xclusion of  the  covariates  that  presented  critical  p-values
values that  were  not  signiﬁcant).  This  step  was  repeated
ntil all  variables  remaining  in  the  model  presented  p  <  0.05.
or statistical  analysis,  the  cut-off  probability  for  rejecting
he null  hypothesis  was  deﬁned  as  less  than  5%  (p  <  0.05).
ll analyzes  were  performed  using  the  Statistical  Package
or Social  Sciences  (SPSS)  v.13  (SPSS  Inc,  Chicago,  IL).
This  study  was  approved  by  the  institutional  review
oards of  all  six  hospitals,  which  did  not  require  informed
onsent due  to  the  retrospective  design  of  the  study.  Conﬁ-
entiality regarding  patients’  identity  was  ensured.
esults
he  hospital  records  of  136  children  admitted  with  con-
rmed inﬂuenza  A  (H1N1)pdm09  between  July  2  and  October
5 of  2009  in  Porto  Alegre  were  reviewed.  During  this  period,
he hospitals  reported  450  potential  cases  of  inﬂuenza
(H1N1)pdm09 in  children  younger  than  14  years  of  age.
f these,  437  children  were  tested  with  RT-PCR,  with  136
ositive results  (31.1%  of  those  tested).  Records  for  16  chil-
ren were  not  found.  Table  1  presents  the  demographic
eatures of  the  remaining  120  patients.  Thirteen  patients
ere from  the  private  hospital,  45  were  from  partially
rivate hospitals,  and  62  were  from  public  institutions.
eventy-one patients  were  male  (59%),  and  the  median  age
as  17.5  months  old.  Among  the  52  patients  with  CD,  the
ollowing diseases  were  identiﬁed,  with  their  respective
umber of  patients:  neurologic  impairment  (17);  asthma
10); wheezing  infants  (seven);  preterm  infants  (ﬁve  with
nd two  without  bronchopulmonary  dysplasia);  malignan-
ies receiving  chemotherapy  (ﬁve);  obliterans  bronchiolitis
two); and  laryngotracheomalacia,  asplenia,  corticother-
py in  immunosuppressive  dose  (2  mg/kg/day  for  more  than
wo weeks),  short  bowel  syndrome,  and  colostomy,  with
ne patient  each.  Bacterial  co-detection  occurred  in  eight
atients (6.7%),  and  this  predictor  was  excluded  from  the
odel due  to  its  low  prevalence.  Blood  cell  counts  were
lso excluded  from  the  analysis  because  these  data  were
ot available  in  a  substantial  proportion  of  patients  at  admis-
ion. DFA  was  performed  in  103  of  the  120  children,  and  viral
o-detection was  observed  in  16  patients  (15.5%).
Risk  factors  in  children  with  inﬂuenza  A(H1N1)pdm09  
Table  1  Characteristics  of  120  hospitalized  children  with
inﬂuenza A(H1N1)pdm09  during  the  ﬁrst  pandemic  wave  in
Porto  Alegre,  Brazil,  July  2  to  October  15,  2009.
Characteristics  Findings
Male  (number,  %)  71  (59)
Age (months),  (median,  IR)  17.5  (5-67)
Chronic diseases  (number,  %)  52  (43)
Viral co-detection  (number,  %) 16 (15.5)
Oseltamivir treatment  (number,  %)
No  treatment 25  (21)
Within 48  hours  from  onset  of  signs
and symptoms
15  (13)
After 48  hours  from  onset  of  signs
and symptoms
80  (67)
Abnormal chest  X-ray  99  (92.5)
Length of  hospital  stay  (days),
(median, IR)
9  (5-19)
Patients undergoing  MV  (number,  %)  29  (24)
Days to  need  MV  (median,  IR)  6  (3-10)
Deaths (number,  %)  11  (9)
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missing data  in  17  patients  for  this  predictor,  together  with
the low  sensitivity  of  DFA  for  viruses  tested  and  the  inabilityIR, interquartile range; MV, mechanical ventilation.
Patients  not  tested  with  DFA  presented  a  similar  MV/non-
MV ratio  (ﬁve  of  these  patients  needed  MV).  The  other
viruses found  (and  respective  number  of  detections)  were:
RSV (12),  inﬂuenza  B  (two),  adenovirus  (two),  and  parain-
ﬂuenza type  3  (two).  Two  patients  had  two  additional
viruses detected.  Inﬂuenza  A(H1N1)pdm09  detection  with
DFA was  achieved  in  55.3%  (57  patients)  of  patients  tested.
Reports of  chest  X-ray  were  available  for  107  patients.  All
others predictors  had  no  missing  data.  Forty-ﬁve  children
were admitted  to  an  ICU,  41  were  admitted  to  a  pediatric
ward, and  34  were  admitted  to  an  emergency  unit.  MV  was
required in  29  patients  (24.2%),  and  11  (9.1%)  of  them  died.
o
n
Table  2  Univariate  analysis  of  association  between  need  for  mec
Predictors  Prevalence  ratio  
Gender  (male)  0.978  
Age (months)  0.996  
Chronic diseases  2.140  
Viral  co-detection 2.239 
Oseltamivir:
Within  48  hours  0.360  
After 48  hours  0.788  
Abnormal chest  X-ray  2.864  
* p < 0.05.
Table  3  Multivariate  analysis  of  association  between  need  for  m
Predictors  Prevalence  ratio  
Chronic  diseases  2.613  
Viral  co-detection  2.430  
* p < 0.05.447
ables  2  and  3  show  the  results  of  bivariate  and  multivariate
nalyses for  risk  of  MV,  respectively.
CD  (PR  2.613;  95%  CI  1.267-5.386;  p  =  0.009)  and  viral
o-detection (PR  2.430;  95%  CI  1.203-4.905;  p  =  0.013)  were
tatistically associated  with  increased  risk  in  multivariate
nalysis. Table  4  details  all  pediatric  deaths.
iscussion
imilarly  to  previous  studies,  this  study  found  that  CD  pre-
isposes to  worse  outcome.10,11 Furthermore,  a  statistically
igniﬁcant association  was  found  between  viral  co-detection
nd need  for  MV,  a  ﬁnding  that,  to  the  authors’  knowledge,
as only  observed  in  one  previous  study  in  children  IN  WHICH
orres et  al.  found  viral  co-detection  with  RSV  as  a  predic-
or of  death  in  a  multivariable  analysis  in  children  admitted
uring the  ﬁrst  pandemic  wave  in  Argentina.17 Esper  et  al.
lso found  worse  outcome  in  a  mixed  sample  of  both  adults
nd children  using  RT-PCR.18 A  minority  of  reports  in  pedi-
tric patients  mention  the  prevalence  of  viral  co-detection,
uggesting that  tests  for  other  viruses  were  not  routinely
erformed in  most  situations.10,19--22 Although  some  studies
ith other  viruses,  such  as  RSV,  did  not  show  worse  prog-
osis when  two  or  more  viruses  were  detected,  the  authors
elieve that  co-detection  of  inﬂuenza  A(H1N1)pdm09  with
ther viruses  could  lead  to  more  serious  damage  to  the  air-
ays. This  might  be  caused  by  immune  response,  since  Esper
t al.  have  shown  that  inﬂuenza  titers  were  not  altered  by
o-infection.18,23
The  limited  sensitivity  of  DFA  for  most  of  respiratory
iruses is  a  limitation  of  the  present  study,  as  well  as  in
he study  of  Torres  et  al.,  as  tests  for  other  viruses  were
erformed with  DFA  in  both  studies;  the  prevalence  of  15.5%
bserved in  the  present  study  may  be  underestimated.24 Thef this  test  to  detect  other  prevalent  viruses  (such  as  rRhi-
ovirus) could  bias  the  present  results.  The  ﬁnding  of  55.3%
hanical  ventilation  and  potential  predictors.
95%  conﬁdence  interval  p-value
0.514--1.86  0.945
0.989--1.004  0.335
1.109--4.13  0.023*
1.111--4.510  0.024*
0.100--1.295  0.118
0.352--1.760  0.561
0.737--11.123  0.129
echanical  ventilation  and  potential  predictors.
95%  conﬁdence  interval  p-value
1.267--5.386  0.009*
1.203--4.905  0.013*
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Table  4  Characteristics  of  11  children  who  died  with  inﬂuenza  A(H1N1)pdm09  infection  in  Porto  Alegre,  Brazil,  from  July  2  to
October  15,  2009.
Gender  Age  Chronic  disease  Viral  co-detection  Oseltamivira Chest  X-ray  ﬁndings
at admission
Female  9  years  Acute  lymphocytic  leukemia  Not  detected  >  48  hours  Normal
Female 3  months  None  RSV  <  48  hours  DII/consolidation
Male 4  years  Neurologic  impairment  Not  performed  <  48  hours  DII/consolidation
Male 7  months Bronchopulmonary  dysplasia  Parainﬂuenza  3  No  Normal
Male 5  months Acute  myeloid  leukemia Not  detected  >  48  hours  DII/consolidation
Male 2  years Histiocytosis  Not  performed No  Consolidation
Male 1  month Bronchopulmonary  dysplasia Not  detected >  48  hours DII
Male 9  years  Neurologic  impairment  Not  detected  >  48  hours  DII
Female 1  year  Neurologic  impairment  Not  detected  >  48  hours  DII
Male 11  years  Neurologic  impairment  Not  detected  >  48  hours  DII  +Consolidation
Female  6  years  Neurologic  impairment  Not  detected  >  48  hours  Not  available
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DII, diffuse interstitial inﬁltrate.
nﬂuenza  A(H1N1)pdm09  detection  with  DFA  compared  with
T-PCR highlights  the  low  sensitivity  of  DFA,  although  most
tudies show  sensitivities  higher  than  that  found  in  the
resent study.24 Nevertheless,  only  two  studies  in  hospi-
alized pediatric  population  with  inﬂuenza  A(H1N1)pdm09
uring the  ﬁrst  pandemic  wave  in  Argentina  reported  a
igher prevalence  of  viral  co-detection  (19%  and  25%).10,17
nother  study  in  outpatients  performed  in  Recife,  Brazil,
howed 78%  of  viral  co-detection,  but  the  detection  of
ther viruses  was  performed  by  multiplex  RT-PCR,  which
ould, at  least  partially,  explain  the  higher  prevalence  of
o-detection.25 It  is  interesting  that  both  studies  with  higher
revalence of  co-detection  than  the  present  study  were  also
erformed in  South  America.
It  is  also  important  to  highlight  the  characteristics  of
ediatric deaths  in  the  present  patients,  shown  in  Table  4,
s they  followed  a  similar  pattern  of  risk  factors  found
sing need  for  MV  as  outcome.  All  but  one  patient  had
mportant CD,  reinforcing  the  association  between  this  risk
actor with  a  worse  outcome.  The  single  patient  who  did
ot present  such  conditions  was  only  3  month-old  and
ad co-detection  of  RSV.  No  association  of  early  initia-
ion of  oseltamivir  with  lower  incidence  of  respiratory
omplications was  found.  This  possible  predictor  was  cat-
gorized instead  of  using  it  as  a  continuous  variable,  mainly
ue to  the  difﬁculties  to  precisely  deﬁne  the  beginning  of
igns and  symptoms  in  days,  which  might  have  resulted
n loss  of  statistical  power.  However,  there  is  a  lack  of
vidence regarding  the  efﬁcacy  of  this  drug  in  preventing
erious respiratory  complications  in  most  studies.26 Inter-
stingly, some  authors  suggested,  using  animal  models,
hat more  than  one  antiviral  drug  is  necessary  to  pre-
ent complications  in  inﬂuenza  A(H1N1)pdm09  infections.27
o  association  was  found  between  abnormalities  on  chest
-rays and  need  for  MV,  but  this  analysis  had  serious  limi-
ations because  the  authors  only  had  access  to  reports  of
ndings. As  this  was  a  retrospective  study,  it  has  several
imitations, such  as  loss  and  lack  of  accurate  data,  which
ed to  the  exclusion  of  blood  cell  count  from  the  analysis,
or example,  besides  all  aforementioned  limitations.  It  was
ot possible  to  know  whether  the  16  patients  not  includedonset.
iased  the  ﬁndings,  since  their  demographic  data  was  not
ssessed.
Nevertheless, the  authors  believe  that  the  present  study
s relevant  because  it  is  one  of  the  ﬁrst  to  assess  risk
actors for  respiratory  complications  in  Brazilian  children
ith inﬂuenza  A(H1N1)pdm09  infections,  since  there  are
ew reports  assessing  pediatric  hospitalizations  during  the
andemic in  Brazil.28 The  present  ﬁndings  highlight  that
ll deaths  occurred  in  the  group  indicated  for  antiviral
reatment by  the  local  public  health  authorities’  recom-
endations during  the  pandemic,  reinforcing  that  high  risk
roups of  children  are  more  predictable  than  those  of  adults,
n which  more  than  30%  of  deaths  usually  occur  in  patients
ithout an  identiﬁable  predictor  of  poorer  outcome.29 This
nformation is  very  helpful  to  guide  future  preventive  and
herapeutic interventions.  Viral  co-detection  may  be  a  new
dentiﬁed predictor  of  complications,  although  more  studies
re necessary  to  conﬁrm  this  association,  preferably  using
ore sensitive  techniques  such  as  RT-PCR.
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